CDC investigating reports of contaminated ultrasound gel
The Centers for Disease Control and Prevention is assisting in a multistate investigation on the use of contaminated non-sterile ultrasound gel for ultrasound-guided percutaneous procedures. Reports of Paraburkholderia fungorum detected in blood cultures from patients across multiple health care facilities prompted the investigation, and the CDC said it was aware of 40 confirmed cases of the bacteria in four states and two other countries as of May 8. Tests found at least two contaminated products under the MediChoice and ClearImage brands that are manufactured by NEXT Medical Products Company. The CDC provided a series of recommendations for health care providers to ensure patient safety and prevent potential outbreaks.
Related News Articles
Blog
In think‑tank reports, like the one released this week by Paragon Health Institute, hospitals are often reduced to abstractions — payment rates, charts,…
Chairperson's File
More than 1,000 leaders from hospitals and health systems across the country will gather in Washington, D.C., early next week at the 2026 AHA Annual…
Perspective
Few patient populations are more vulnerable to the shifting winds around health care today than Medicare beneficiaries who need specialized, high-acuity and…
Headline
The Centers for Medicare & Medicaid Services April 2 issued a proposed rule that would update hospice payment rates for fiscal year 2027. Overall, CMS…
Headline
Scott Edelman, executive director of Burke Rehabilitation, shares how post-acute care hospitals are helping relieve pressure on acute care facilities, and how…
Headline
A group of hospital stakeholders, including the AHA, the Federation of American Hospitals, the National Association of Long Term Hospitals and the Coalition of…